| scholarly article | Q13442814 |
| P50 | author | Leland W K Chung | Q92165159 |
| P2093 | author name string | Jack L Arbiser | |
| Shi-Yong Sun | |||
| Masato Fujisawa | |||
| Babette Weksler | |||
| Haiyen E Zhau | |||
| Akinobu Gotoh | |||
| Majd Zayzafoon | |||
| Peter A S Johnstone | |||
| Katsumi Shigemura | |||
| P2860 | cites work | TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 |
| Facile purification of honokiol and its antiviral and cytotoxic properties | Q24634992 | ||
| Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis | Q24669763 | ||
| Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis | Q24683768 | ||
| Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo | Q28180577 | ||
| Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production | Q28185379 | ||
| The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells | Q28242842 | ||
| Free radicals, metals and antioxidants in oxidative stress-induced cancer | Q29547711 | ||
| Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
| Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines | Q30472489 | ||
| Docetaxel-based chemotherapy as second-line treatment for paclitaxel-based chemotherapy-resistant hormone-refractory prostate cancer: a pilot study | Q33365485 | ||
| Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts | Q33865977 | ||
| Risks and benefits of taxanes in breast and ovarian cancer | Q34086098 | ||
| A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death | Q34346499 | ||
| Docetaxel (taxotere) in the treatment of prostate cancer | Q35160177 | ||
| Honokiol: a potent chemotherapy candidate for human colorectal carcinoma | Q36076361 | ||
| Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale | Q36469810 | ||
| Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. | Q36496451 | ||
| Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells | Q40297376 | ||
| Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol | Q40331374 | ||
| Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation | Q40369516 | ||
| Preclinical pharmacology of docetaxel | Q40423968 | ||
| Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer | Q41060508 | ||
| Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells | Q41749690 | ||
| Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kappaB, elicits caspase activity, and enhances cytotoxicity | Q42832279 | ||
| Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation | Q42834585 | ||
| Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways | Q43606331 | ||
| Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells | Q43990741 | ||
| Weekly low-dose docetaxel in advanced hormone-resistant prostate cancer patients previously exposed to chemotherapy | Q44448970 | ||
| Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria | Q44474018 | ||
| Weekly administration of docetaxel for symptomatic metastatic hormone‐refractory prostate carcinoma | Q44611369 | ||
| Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro | Q45242772 | ||
| Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. | Q51503680 | ||
| A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis | Q79129693 | ||
| Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway | Q80243492 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1279-89 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells | |
| P478 | volume | 109 |
| Q36923286 | Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells |
| Q39470506 | Antimetastatic activity of honokiol in osteosarcoma |
| Q37615079 | Antineoplastic Effects of Honokiol on Melanoma |
| Q54987090 | Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds. |
| Q37071477 | Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway |
| Q34547088 | Crude extract of Rheum palmatum L induced cell death in LS1034 human colon cancer cells acts through the caspase-dependent and -independent pathways |
| Q36801771 | Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ β -Catenin Signaling and Apoptosis Induction |
| Q54976478 | Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells. |
| Q47694519 | Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin. |
| Q24614006 | Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis |
| Q34143126 | Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells |
| Q38104756 | Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. |
| Q28487716 | Honokiol dimers and magnolol derivatives with new carbon skeletons from the roots of Magnolia officinalis and their inhibitory effects on superoxide anion generation and elastase release |
| Q28540108 | Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis |
| Q50057469 | Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo |
| Q64063205 | Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway |
| Q39527075 | Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells. |
| Q37625379 | Honokiol inhibits androgen receptor activity in prostate cancer cells |
| Q33854787 | Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors |
| Q33563809 | Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis |
| Q45903004 | Honokiol inhibits hypoxia-inducible factor-1 pathway. |
| Q48176419 | Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy |
| Q38890499 | Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling |
| Q37380664 | Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells |
| Q38858961 | Honokiol targets mitochondria to halt cancer progression and metastasis |
| Q24619765 | Honokiol, a multifunctional antiangiogenic and antitumor agent |
| Q28246944 | Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function |
| Q92256527 | Honokiol: A Review of Its Anticancer Potential and Mechanisms |
| Q27027050 | Honokiol: a novel natural agent for cancer prevention and therapy |
| Q27025151 | Identifying new small molecule anti-invasive compounds for glioma treatment |
| Q33360446 | Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model |
| Q92642157 | Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol |
| Q90084660 | Neuraminidase 1 regulates proliferation, apoptosis and the expression of Cadherins in mammary carcinoma cells |
| Q93132954 | Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload |
| Q35599714 | Phospholipase D: enzymology, functionality, and chemical modulation |
| Q55491670 | Phyto-polyphenols as potential inhibitors of breast cancer metastasis. |
| Q37640924 | Plant-derived anticancer agents: a promising treatment for bone metastasis |
| Q38754284 | Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies |
| Q37042612 | Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells |
| Q55461257 | Synthesis of tetrahydrohonokiol derivates and their evaluation for cytotoxic activity against CCRF-CEM leukemia, U251 glioblastoma and HCT-116 colon cancer cells. |
| Q38261369 | The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer |
| Q37374435 | The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. |
| Q38786015 | Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy |
| Q37216917 | c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells |
Search more.